CAR T cell therapy: inroads to response and resistance

被引:156
作者
Brown, Christine E. [1 ]
Mackall, Crystal L. [2 ]
机构
[1] City Hope Natl Med Ctr, Immunotherapy, Duarte, CA 91010 USA
[2] Stanford Univ, Pediat & Med, Stanford, CA 94305 USA
关键词
D O I
10.1038/s41577-018-0119-y
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Here, we highlight key papers published in 2018 that advance our understanding of resistance to chimeric antigen receptor (CAR) T cell immunotherapy for leukaemia and lymphoma and in so doing reveal barriers that must be addressed to increase efficacy of this novel class of therapeutics for B cell malignancies and expand their reach to solid tumours.
引用
收藏
页码:73 / 74
页数:2
相关论文
共 10 条
[1]   CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum [J].
Bagashev, Asen ;
Sotillo, Elena ;
Tang, Chih-Hang Anthony ;
Black, Kathryn L. ;
Perazzelli, Jessica ;
Seeholzer, Steven H. ;
Argon, Yair ;
Barrett, David M. ;
Grupp, Stephan A. ;
Hu, Chih-Chi Andrew ;
Thomas-Tikhonenko, Andrei .
MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (21)
[2]   T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma [J].
Brudno, Jennifer N. ;
Maric, Irina ;
Hartman, Steven D. ;
Rose, Jeremy J. ;
Wang, Michael ;
Lam, Norris ;
Stetler-Stevenson, Maryalice ;
Salem, Dalia ;
Yuan, Constance ;
Pavletic, Steven ;
Kanakry, Jennifer A. ;
Ali, Syed Abbas ;
Mikkilineni, Lekha ;
Feldman, Steven A. ;
Stroncek, David F. ;
Hansen, Brenna G. ;
Lawrence, Judith ;
Patel, Rashmika ;
Hakim, Frances ;
Gress, Ronald E. ;
Kochenderfer, James N. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) :2267-+
[3]   Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells [J].
Fraietta, Joseph A. ;
Nobles, Christopher L. ;
Sammons, Morgan A. ;
Lundh, Stefan ;
Carty, Shannon A. ;
Reich, Tyler J. ;
Cogdill, Alexandria P. ;
Morrissette, Jennifer J. D. ;
DeNizio, Jamie E. ;
Reddy, Shantan ;
Hwang, Young ;
Gohil, Mercy ;
Kulikovskaya, Irina ;
Nazimuddin, Farzana ;
Gupta, Minnal ;
Chen, Fang ;
Everett, John K. ;
Alexander, Katherine A. ;
Lin-Shiao, Enrique ;
Gee, Marvin H. ;
Liu, Xiaojun ;
Young, Regina M. ;
Ambrose, David ;
Wang, Yan ;
Xu, Jun ;
Jordan, Martha S. ;
Marcucci, Katherine T. ;
Levine, Bruce L. ;
Garcia, K. Christopher ;
Zhao, Yangbing ;
Kalos, Michael ;
Porter, David L. ;
Kohli, Rahul M. ;
Lacey, Simon F. ;
Berger, Shelley L. ;
Bushman, Frederic D. ;
June, Carl H. ;
Melenhorst, J. Joseph .
NATURE, 2018, 558 (7709) :307-+
[4]   Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia [J].
Fraietta, Joseph A. ;
Lacey, Simon F. ;
Orlando, Elena J. ;
Pruteanu-Malinici, Iulian ;
Gohil, Mercy ;
Lundh, Stefan ;
Boesteanu, Alina C. ;
Wang, Yan ;
O'Connor, Roddy S. ;
Hwang, Wei-Ting ;
Pequignot, Edward ;
Ambrose, David E. ;
Zhang, Changfeng ;
Wilcox, Nicholas ;
Bedoya, Felipe ;
Dorfmeier, Corin ;
Chen, Fang ;
Tian, Lifeng ;
Parakandi, Harit ;
Gupta, Minnal ;
Young, Regina M. ;
Johnson, F. Brad ;
Kulikovskaya, Irina ;
Liu, Li ;
Xu, Jun ;
Kassim, Sadik H. ;
Davis, Megan M. ;
Levine, Bruce L. ;
Frey, Noelle V. ;
Siegel, Donald L. ;
Huang, Alexander C. ;
Wherry, E. John ;
Bitter, Hans ;
Brogdon, Jennifer L. ;
Porter, David L. ;
June, Carl H. ;
Melenhorst, J. Joseph .
NATURE MEDICINE, 2018, 24 (05) :563-+
[5]   CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy [J].
Fry, Terry J. ;
Shah, Nirali N. ;
Orentas, Rimas J. ;
Stetler-Stevenson, Maryalice ;
Yuan, Constance M. ;
Ramakrishna, Sneha ;
Wolters, Pamela ;
Martin, Staci ;
Delbrook, Cindy ;
Yates, Bonnie ;
Shalabi, Haneen ;
Fountaine, Thomas J. ;
Shern, Jack F. ;
Majzner, Robbie G. ;
Stroncek, David F. ;
Sabatino, Marianna ;
Feng, Yang ;
Dimitrov, Dimiter S. ;
Zhang, Ling ;
Sang Nguyen ;
Qin, Haiying ;
Dropulic, Boro ;
Lee, Daniel W. ;
Mackall, Crystal L. .
NATURE MEDICINE, 2018, 24 (01) :20-+
[6]   Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia [J].
Maude, S. L. ;
Laetsch, T. W. ;
Buechner, J. ;
Rives, S. ;
Boyer, M. ;
Bittencourt, H. ;
Bader, P. ;
Verneris, M. R. ;
Stefanski, H. E. ;
Myers, G. D. ;
Qayed, M. ;
De Moerloose, B. ;
Hiramatsu, H. ;
Schlis, K. ;
Davis, K. L. ;
Martin, P. L. ;
Nemecek, E. R. ;
Yanik, G. A. ;
Peters, C. ;
Baruchel, A. ;
Boissel, N. ;
Mechinaud, F. ;
Balduzzi, A. ;
Krueger, J. ;
June, C. H. ;
Levine, B. L. ;
Wood, P. ;
Taran, T. ;
Leung, M. ;
Mueller, K. T. ;
Zhang, Y. ;
Sen, K. ;
Lebwohl, D. ;
Pulsipher, M. A. ;
Grupp, S. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) :439-448
[7]   Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma [J].
Neelapu, S. S. ;
Locke, F. L. ;
Bartlett, N. L. ;
Lekakis, L. J. ;
Miklos, D. B. ;
Jacobson, C. A. ;
Braunschweig, I. ;
Oluwole, O. O. ;
Siddiqi, T. ;
Lin, Y. ;
Timmerman, J. M. ;
Stiff, P. J. ;
Friedberg, J. W. ;
Flinn, I. W. ;
Goy, A. ;
Hill, B. T. ;
Smith, M. R. ;
Deol, A. ;
Farooq, U. ;
McSweeney, P. ;
Munoz, J. ;
Avivi, I. ;
Castro, J. E. ;
Westin, J. R. ;
Chavez, J. C. ;
Ghobadi, A. ;
Komanduri, K. V. ;
Levy, R. ;
Jacobsen, E. D. ;
Witzig, T. E. ;
Reagan, P. ;
Bot, A. ;
Rossi, J. ;
Navale, L. ;
Jiang, Y. ;
Aycock, J. ;
Elias, M. ;
Chang, D. ;
Wiezorek, J. ;
Go, W. Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) :2531-2544
[8]   Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia [J].
Orlando, Elena J. ;
Han, Xia ;
Tribouley, Catherine ;
Wood, Patricia A. ;
Leary, Rebecca J. ;
Riester, Markus ;
Levine, John E. ;
Qayed, Muna ;
Grupp, Stephan A. ;
Boyer, Michael ;
De Moerloose, Barbara ;
Nemecek, Eneida R. ;
Bittencourt, Henrique ;
Hiramatsu, Hidefumi ;
Buechner, Jochen ;
Davies, Stella M. ;
Verneris, Michael R. ;
Nguyen, Kevin ;
Brogdon, Jennifer L. ;
Bitter, Hans ;
Morrissey, Michael ;
Pierog, Piotr ;
Pantano, Serafino ;
Engelman, Jeffrey A. ;
Winckler, Wendy .
NATURE MEDICINE, 2018, 24 (10) :1504-+
[9]   Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL [J].
Rossi, John ;
Paczkowski, Patrick ;
Shen, Yueh-Wei ;
Morse, Kevin ;
Flynn, Brianna ;
Kaiser, Alaina ;
Ng, Colin ;
Gallatin, Kyle ;
Cain, Tom ;
Fan, Rong ;
Mackay, Sean ;
Heath, James R. ;
Rosenberg, Steven A. ;
Kochenderfer, James N. ;
Zhou, Jing ;
Bot, Adrian .
BLOOD, 2018, 132 (08) :804-814
[10]   Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy [J].
Sotillo, Elena ;
Barrett, David M. ;
Black, Kathryn L. ;
Bagashev, Asen ;
Oldridge, Derek ;
Wu, Glendon ;
Sussman, Robyn ;
Lanauze, Claudia ;
Ruella, Marco ;
Gazzara, Matthew R. ;
Martinez, Nicole M. ;
Harrington, Colleen T. ;
Chung, Elaine Y. ;
Perazzelli, Jessica ;
Hofmann, Ted J. ;
Maude, Shannon L. ;
Raman, Pichai ;
Barrera, Alejandro ;
Gill, Saar ;
Lacey, Simon F. ;
Melenhorst, Jan J. ;
Allman, David ;
Jacoby, Elad ;
Fry, Terry ;
Mackall, Crystal ;
Barash, Yoseph ;
Lynch, Kristen W. ;
Maris, John M. ;
Grupp, Stephan A. ;
Thomas-Tikhonenko, Andrei .
CANCER DISCOVERY, 2015, 5 (12) :1282-1295